Refine by
Immuno Oncology Articles & Analysis: Older
9 articles found
Some therapeutic areas and scenarios like immuno-oncology, multi-arm trials also add new levels of complexity to clinical trials. ...
ByClinion
Currently, researches on monoclonal antibody drugs development expand the range to immuno-oncology, targeted therapy, and immunotherapy. Researchers have proposed more prospects for monoclonal antibody therapy drugs, such as the development of personalized drugs and combination therapy. ...
The Challenge: One of the most common challenges in immuno-oncology is identifying the indications and patient populations that would benefit from a specific therapy, especially on top of Standard of Care (SOC) treatments. ...
Abera’s vaccine delivery platform works as a plug-and-play system where known or novel antigens can be engineered onto our delivery platform to create effective, multivalent vaccines that are cost-effective and fast to produce. We actively work together with academia and industry to enable the use of our vaccine delivery platform in design and development of new vaccines. Many of these ...
Leading iPSC engineering at Umoja, she comes back on the vision of Umoja, its RACR™ technology and her interest in TreeFrog’s C-Stem™ platform for the development of iPSC-derived allogeneic products in immuno-oncology. To see video, please click ...
Insilico Medicine announced the nomination of a novel preclinical therapeutic candidate for treating COVID-19, designed using the generative chemistry AI platform Chemistry42. The new drug candidate is a 3CL protease inhibitor unique from existing drugs in its class because it can be rapidly produced. While this nomination is a potentially important development for the ongoing COVID-19 pandemic ...
Planning and executing oncology trials can quickly become complex, mainly for the following reasons: Budgets: Phase 2 and 3 oncology trial budgets are nearly double those of non-oncology trials, per patient enrolled. Timelines: Regardless of phase, oncology trials, last 14-18 months longer than ...
He also talks about the importance of and future opportunity for bioinformatics and shares his thoughts on the broader recognition of early detection that started to gain momentum in immuno-oncology but has now expanded to other treatment ...
Alcyone Lifesciences is a medical technology company based out of Lowell, MA, which specializes in central nervous system (CNS) drug delivery platforms for targeted infusions of the brain or spinal cord. Their Thecaflex DRx System was recently awarded Breakthrough Device designation by the FDA, for spinal infusion of therapeutic medications. Medgadget had the opportunity to speak with Alcyone ...